Product Images Enalapril Maleate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Enalapril Maleate NDC 70518-3874 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 01

Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 01

Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 02

Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 02

Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 03

Image - 37366051 ccb9 4ce6 9060 0d4fa9e00a66 03

Creatinine Initial Dose mg/day: 5 mg/day for patients with normal renal function (>80 mL/min). For patients with mild impairment (30-80 mL/min), the initial dose is also 5 mg/day. For patients with moderate to severe impairment (<30 mL/min), the initial dose is 25 mg/day. For dialysis patients, the dose is 25 mg on dialysis days. It is important to note that there may be an increased risk of Anaphylactoid Reactions during Membrane Exposure. The dosage on nondialysis days should be adjusted based on the blood pressure response.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Enalapril Maleate is a medication available in the form of tablets. Each tablet contains 10 mg of the active ingredient. This particular package consists of 90 tablets. It is important to protect the medication from moisture. Please note that the remaining text appears to be illegible or not relevant for description.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.